Personalized Stem Cell Therapies for Tissue Regeneration
Sheldon Schaffer, Vice President, Aastrom Biosciences, Speaking at Stem Cells World Congress 2010.
Double Knockdown of Transcription Factors DP1 and DP2 Revealed Their Unique Roles in the Regulation of Matrix Metalloproteinase as Well as Cell Cycle Progression
Kenichi Yoshida, Associate Professor, Meiji University, speaking at European Biomarkers Summit 2009
Cancer Biomarkers for Diagnosis and Therapy Prediction
Ralph Schiess, ETH, Researcher, speaking at Cancer Proteomics 2010.
Blood-Based Exopeptidase Activities as Biomarkers for Cancer
Paul Tempst, Memorial Sloan-Kettering Cancer Center, Professor, speaking at Cancer Proteomics 2010.
Domain Antibody-Based Arrays for Breast Cancer Diagnostic
Klervi Even, Inserm, speaking at Cancer Proteomics 2010.
Clinical Proteomics – Ready for Prime Time in Urological Cancer Diagnostics?
Eric Schiffer, Mosaiques Diagnostics, Clinical Project Manager, speaking at Cancer Proteomics 2010.
Application of Profiling the Antibody Repertoire for Discovery of Cancer Biomarkers.
Delores Cahill, University College Dublin, Professor, speaking at Cancer Proteomics 2010.
13CO2 a Biomarker in Breath for Individualized Cancer Therapy
Anil Modak, Cambridge Isotope Laboratory, Associate Director, speaking at Cancer Proteomics 2010.
The Foundation of the NIH (FNIH) Biomarkers Consortium Builds Consensus Through Public Private Partnerships
Maria Vassileva, Scientific Program Manager, Foundation for the National Institutes of Health, speaking at European Biomarkers Summit 2009